Phase 1 Acute Kidney Injury Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
Theophylline Prophylaxis During Hypothermia to Limit Neonatal Nephron Damage
Acute Kidney InjuryHIE
Medical College of Wisconsin30 enrolled1 locationNCT05853601
Recruiting
Phase 1Phase 2
Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury
Acute Kidney Injury
Hope Biosciences LLC70 enrolled3 locationsNCT06654193
Recruiting
Phase 1
Prophylactic Methylprednisolone for Renal Protection in Cardiac Surgeries With Cardiopulmonary Bypass
AKI - Acute Kidney InjuryCardiopulmonary Bypass
Ain Shams University170 enrolled1 locationNCT06917859
Completed
Phase 1
A Single Infusion Study of DUR-928 in Healthy Volunteers
Acute Kidney Injury
INC Research16 enrolled1 locationACTRN12616000856415
Completed
Phase 1
A Single and Multiple Daily Injection Study of DUR-928 in Healthy Volunteers.
Other Types of Acute Organ InjuryAcute Kidney Injury (AKI)
INC Research44 enrolled1 locationACTRN12615000903583